<DOC>
	<DOCNO>NCT00343252</DOCNO>
	<brief_summary>The purpose study determine daily teriparatide reduce back pain effectively weekly risedronate woman osteoporosis chronic back pain due spinal bone fracture .</brief_summary>
	<brief_title>Effect Teriparatide Compared Risedronate Back Pain Women With Spine Fracture Caused Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Postmenopausal woman 45 year old . No period least two year . History back pain start least 2 month prior initial visit ( likely due spinal bone fracture determine investigator ) . Minimum one moderate spinal bone fracture . Beginning pain level least four eleven point scale . Bone Mineral Density ( BMD ) must meet criterion Able read , understand , administer selfquestionnaires . Be willing able use peninjector deliver medication . Are increase risk osteosarcoma . Have active suspect disease affect bone metabolism osteoporosis . Participants already know require procedure repair spinal bone fracture . Abnormal value certain lab test . Anything would make difficult determine back pain due fracture . Poor medical psychiatric condition . Alcohol drug abuse within year study start . Certain malignant neoplasm 5 year prior enrollment . Active liver disease clinical jaundice . Significantly impaired renal function . History nephrolithiasis urolithiasis within 2 year prior enrollment . Known contraindication intolerance risedronate and/or teriparatide therapy . Treatment oral strontium certain therapeutic dos fluoride .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>